Roivant Sciences (ROIV) Shares Repurchased (2020 - 2025)

Roivant Sciences has reported Shares Repurchased for 5 years, with the latest figure at $208.3 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Repurchased fell 79.12% year-over-year to $208.3 million; the trailing twelve-month figure through Dec 2025 stood at $1.4 billion (down 19.28% YoY), and the FY2026 full-year result was $318.1 million, down 75.4% from the prior year.
• Shares Repurchased for Q4 2025 stood at $208.3 million, roughly flat from $208.3 million in the prior quarter.
• The five-year high for Shares Repurchased was $997.8 million in Q4 2024, with the low at -$8.3 million in Q3 2022.
• Historically, Shares Repurchased has averaged $241.5 million across 4 years, with a median of $106.1 million in 2024.
• Annual changes were most pronounced in 2021 — Shares Repurchased surged 205.3% — and 2022, when it tumbled 470.67%.
• Roivant Sciences' Shares Repurchased stood at $2.2 million in 2021, then plunged by 470.67% to -$8.3 million in 2022, then surged by 12079.67% to $997.8 million in 2024, then plunged by 79.12% to $208.3 million in 2025.
• The last three Shares Repurchased figures came in at $208.3 million (Q4 2025), $208.3 million (Q2 2025), and $997.8 million (Q4 2024), per Business Quant data.